Johnson Financial Group Inc (Wisconsin)’s GSK GSK Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.5K	Hold	1,182	–	–	﹤0.01%	448
2026 Q1	$65.8K	Sell	1,182 -123	-9%	-$6.67K	﹤0.01%	446
2025 Q4	$64.5K	Sell	1,305 -3,101	-70%	-$145K	﹤0.01%	474
2025 Q3	$192K	Buy	4,406 +3,224	+273%	+$126K	0.01%	358
2025 Q2	$45.9K	Sell	1,182 -1,649	-58%	-$63K	﹤0.01%	469
2025 Q1	$111K	Buy	+2,831	New	+$104K	0.01%	460
2024 Q4	–	Sell	-146	Closed	-$6.05K	–	896
2024 Q3	$6.05K	Buy	+146	New	+$5.97K	﹤0.01%	751
2024 Q1	–	Sell	-889	Closed	-$33.2K	–	864
2023 Q4	$33.2K	Buy	889 +37	+4%	+$1.33K	﹤0.01%	491
2023 Q3	$31.4K	Sell	852 -725	-46%	-$25.7K	﹤0.01%	439
2023 Q2	$56.8K	Hold	1,577	–	–	﹤0.01%	397
2023 Q1	$57.9K	Buy	+1,577	New	+$55.2K	﹤0.01%	396
2022 Q3	–	Sell	-5,818	Closed	-$317K	–	698
2022 Q2	$317K	Sell	5,818 -1,617	-22%	-$89.3K	0.02%	207
2022 Q1	$405K	Hold	7,435	–	–	0.03%	205
2021 Q4	$410K	Buy	7,435 +851	+13%	+$44.3K	0.03%	207
2021 Q3	$315K	Sell	6,584 -1,171	-15%	-$58.8K	0.02%	220
2021 Q2	$386K	Sell	7,755 -220	-3%	-$10.6K	0.03%	208
2021 Q1	$356K	Buy	7,975 +6,809	+584%	+$309K	0.02%	212
2020 Q4	$54K	Buy	1,166 +345	+42%	+$15.8K	﹤0.01%	317
2020 Q3	$39K	Hold	821	–	–	﹤0.01%	295
2020 Q2	$42K	Hold	821	–	–	﹤0.01%	279
2020 Q1	$39K	Hold	821	–	–	﹤0.01%	300
2019 Q4	$48K	Sell	821 -160	-16%	-$8.9K	﹤0.01%	308
2019 Q3	$52K	Buy	981 +160	+19%	+$8.23K	﹤0.01%	334
2019 Q2	$41K	Hold	821	–	–	﹤0.01%	338
2019 Q1	$43K	Buy	821 +361	+78%	+$18K	﹤0.01%	324
2018 Q4	$22K	Sell	460 -137	-23%	-$6.75K	﹤0.01%	379
2018 Q3	$30K	Sell	597 -23	-4%	-$1.17K	﹤0.01%	369
2018 Q2	$31K	Hold	620	–	–	﹤0.01%	368
2018 Q1	$30K	Hold	620	–	–	﹤0.01%	378
2017 Q4	$27K	Hold	620	–	–	﹤0.01%	405
2017 Q3	$31K	Sell	620 -562	-48%	-$28.5K	﹤0.01%	378
2017 Q2	$64K	Hold	1,182	–	–	0.01%	334
2017 Q1	$62K	Hold	1,182	–	–	0.01%	377
2016 Q4	$57K	Sell	1,182 -559	-32%	-$27.6K	0.01%	388
2016 Q3	$94K	Buy	1,741 +1,121	+181%	+$61.5K	0.01%	342
2016 Q2	$34K	Sell	620 -776	-56%	-$40.9K	﹤0.01%	487
2016 Q1	$70K	Hold	1,396	–	–	0.01%	347
2015 Q4	$70K	Buy	1,396 +248	+22%	+$12.6K	0.01%	346
2015 Q3	$55K	Hold	1,148	–	–	0.01%	454
2015 Q2	$59K	Buy	1,148 +160	+16%	+$9.01K	0.01%	469
2015 Q1	$57K	Sell	988 -164	-14%	-$9.4K	0.01%	493
2014 Q4	$61K	Hold	1,152	–	–	0.01%	458
2014 Q3	$65K	Sell	1,152 -556	-33%	-$34.1K	0.02%	405
2014 Q2	$114K	Hold	1,708	–	–	0.03%	317
2014 Q1	$114K	Sell	1,708 -140	-8%	-$9.46K	0.03%	268
2013 Q4	$123K	Buy	1,848 +156	+9%	+$10.1K	0.04%	257
2013 Q3	$106K	Sell	1,692 -612	-27%	-$39.4K	0.03%	293
2013 Q2	$144K	Buy	+2,304	New	+$146K	0.04%	262

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s GSK Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its GSK (GSK) position steady in Q2 2026 at 1,182 shares worth $62.5K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

Johnson Financial Group Inc (Wisconsin) first reported a position in GSK in Q2 2013 and has held it in 48 quarters since. The position peaked at $410K in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Johnson Financial Group Inc (Wisconsin) held 1,182 shares of GSK worth $62.5K as of Q2 2026.
Johnson Financial Group Inc (Wisconsin) left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #448 holding.
Johnson Financial Group Inc (Wisconsin) first reported a position in GSK in Q2 2013 and has held it in 48 quarters since.
Johnson Financial Group Inc (Wisconsin)'s GSK position peaked at $410K in Q4 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.